| AFP | Alpha-fetoprotein |
| ALBI | Albumin–bilirubin |
| BCLC | Barcelona Clinic Liver Cancer |
| CI | Confidence interval |
| CLEIA | Chemiluminescent enzyme immunoassay |
| CMIA | Chemiluminescent microparticle immunoassay |
| DCP | Des-γ-carboxy prothrombin |
| EIA | Enzyme immunoassay |
| GPC-3 | Glypican-3 |
| HBV | Hepatitis B virus |
| HCC | Hepatocellular carcinoma |
| HCV | Hepatitis C virus |
| HDV | Hepatitis D virus |
| HR | Hazard ratio |
| MASLD | Metabolic dysfunction-associated steatotic liver disease |
| MELD | Model for End-Stage Liver Disease |
| OS | Overall survival |
| PIVKA-II | Protein induced by vitamin K absence-II |
| VEGF | Vascular endothelial growth factor |